Achieve Life Sciences (ACHV) had the highest return in 2001 by a US stock in the Biotechnology Industry, returning 1,336.6%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Achieve Life Sciences (ACHV) | 2001 | 1,336.55% |
Amarin (AMRN) | 2001 | 215.82% |
ImmuCell (ICCC) | 2001 | 131.29% |
Sarepta Therapeutics (SRPT) | 2001 | 129.89% |
Compass Therapeutics (CMPX) | 2001 | 128.89% |
Ionis Pharmaceuticals (IONS) | 2001 | 121.9% |
Capstone Holding Corp Common Stock (CAPS) | 2001 | 68.26% |
Novavax (NVAX) | 2001 | 63.01% |
Gilead Sciences (GILD) | 2001 | 57.41% |
Neurocrine Biosciences (NBIX) | 2001 | 53.24% |
Agenus (AGEN) | 2001 | 46.59% |
Eterna Therapeutics (ERNA) | 2001 | 44% |
Biomarin Pharmaceutical (BMRN) | 2001 | 33.57% |
Ligand Pharmaceuticals (LGND) | 2001 | 30.18% |
Anika Therapeutics (ANIK) | 2001 | 27.99% |
Lifecore Biomedical (LFCR) | 2001 | 25% |
Protalix Biotherapeutics (PLX) | 2001 | 22.67% |
Heron Therapeuti (HRTX) | 2001 | 17.89% |
Vera Therapeutics (VERA) | 2001 | 17.88% |
Soligenix (SNGX) | 2001 | 17.71% |
Enveric Biosciences (ENVB) | 2001 | 11.97% |
Exelixis (EXEL) | 2001 | 10.92% |
Insmed (INSM) | 2001 | 10.12% |
Biogen (BIIB) | 2001 | 9.27% |
Biocardia (BCDA) | 2001 | 9.21% |
